To include your compound in the COVID-19 Resource Center, submit it here.

Entasis raises $31.9M series B-1

Entasis Therapeutics Inc. (Waltham, Mass.) raised $31.9 million in a series B-1 extension with

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE